Rhinostics
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- Undisclosed
Investors
- 3
About Rhinostics
Based in Massachusetts, US, Rhinostics, Inc.D. The FDA (Food and Drug Administration) has approved the RHINOsticTM product as a Class I exempt medical device. Rhinostics' nasal swab collection kits incorporate a one-piece cap-and-swab combination with a barcode on the bottom of the collection vial for automated de-capping and swab removal, as well as simultaneous scanning of several vials. The company generates revenue by offering a system that allows for sample collection, quick accessioning, and automated cap removal, which can be coupled to high throughput Covid-19 tests from laboratory operations.
Who invested in Rhinostics
3 investors across 3 rounds
See all investors in Rhinostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rhinostics
Who invested in Rhinostics?
Rhinostics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rhinostics raised?
Rhinostics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Rhinostics last raise money?
Rhinostics's most recent round on record is a Series A, in Jun 2022.
What does Rhinostics do?
Based in Massachusetts, US, Rhinostics, Inc.
Where is Rhinostics headquartered?
Rhinostics is headquartered in Boston, US.
Which VCs invest in companies like Rhinostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Rhinostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Rhinostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.